Literature DB >> 12662953

Tumour size measurement in an oncology clinical trial: comparison between off-site and on-site measurements.

A L Belton1, S Saini, K Liebermann, G W Boland, E F Halpern.   

Abstract

AIM: To evaluate the degree of variability between lesion measurements obtained by a single observer compared with multiple observers, and in selected cases evaluate which of the two measurements more accurately represented the lesion size.
MATERIALS AND METHODS: In this study we compared the performance of a single off-site observer to multiple on-site observers during measurement of 300 abdominal and thoracic lesions. Lesion measurements that were larger than 1cm(2), differed by more than 50%, but by less than 100%, were compared by a single adjudicator, who was blinded to the measurement source (n=46).
RESULTS: Measurements of the 300 lesions differed by an average of 109% (SD 251%). Of 266 lesions larger than 1cm(2), results of the single observer compared with multiple observers differed by more than 10% for 249 lesions, more than 30% for 169 lesions, more than 50% for 126 lesions, and more than 100% for 66 lesions. Forty-six lesions were compared by the adjudicator. The adjudicator selected the measurement of the single observer for 37 lesions (80.4%), and the measurement determined by one of the multiple observers for nine lesions (19.6%; p=0.00002).
CONCLUSION: Measurement of lesion size by a single observer compared with multiple observers reveals a high degree of variability. An adjudicator selected the measurement of the single observer more frequently than that of multiple observers, with statistical significance. These findings suggest that studies designed to quantify imaging features should limit the number of observers.

Mesh:

Year:  2003        PMID: 12662953     DOI: 10.1016/s0009-9260(02)00577-9

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  14 in total

Review 1.  The use of tumour volumetrics to assess response to therapy in anticancer clinical trials.

Authors:  Gregory V Goldmacher; James Conklin
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

2.  Current standards for response evaluation by imaging techniques.

Authors:  S J Gwyther
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

3.  Augmented Radiologist Workflow Improves Report Value and Saves Time: A Potential Model for Implementation of Artificial Intelligence.

Authors:  Huy M Do; Lillian G Spear; Moozhan Nikpanah; S Mojdeh Mirmomen; Laura B Machado; Alexandra P Toscano; Baris Turkbey; Mohammad Hadi Bagheri; James L Gulley; Les R Folio
Journal:  Acad Radiol       Date:  2020-01       Impact factor: 3.173

4.  Radiology Reports With Hyperlinks Improve Target Lesion Selection and Measurement Concordance in Cancer Trials.

Authors:  Laura B Machado; Andrea B Apolo; Seth M Steinberg; Les R Folio
Journal:  AJR Am J Roentgenol       Date:  2017-02       Impact factor: 3.959

5.  Tool support to enable evaluation of the clinical response to treatment.

Authors:  Mia A Levy; Daniel L Rubin
Journal:  AMIA Annu Symp Proc       Date:  2008-11-06

6.  Improving CT prediction of treatment response in patients with metastatic colorectal carcinoma using statistical learning theory.

Authors:  Walker H Land; Dan Margolis; Ronald Gottlieb; Elizabeth A Krupinski; Jack Y Yang
Journal:  BMC Genomics       Date:  2010-12-01       Impact factor: 3.969

7.  Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: implications for alternative response criteria.

Authors:  Katherine M Krajewski; Mizuki Nishino; Yoko Franchetti; Nikhil H Ramaiya; Annick D Van den Abbeele; Toni K Choueiri
Journal:  Cancer       Date:  2013-11-21       Impact factor: 6.860

8.  Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization.

Authors:  MingDe Lin; Olivier Pellerin; Nikhil Bhagat; Pramod P Rao; Romaric Loffroy; Roberto Ardon; Benoit Mory; Diane K Reyes; Jean-François Geschwind
Journal:  J Vasc Interv Radiol       Date:  2012-12       Impact factor: 3.464

9.  Volume assessment accuracy in computed tomography: a phantom study.

Authors:  Nicolas D Prionas; Shonket Ray; John M Boone
Journal:  J Appl Clin Med Phys       Date:  2010-04-16       Impact factor: 2.102

Review 10.  RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline.

Authors:  Els L van Persijn van Meerten; Hans Gelderblom; Johan L Bloem
Journal:  Eur Radiol       Date:  2009-12-22       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.